Supernus Pharmaceuticals Inc
F:S49
Supernus Pharmaceuticals Inc
F:S49
Price:
41.8
EUR
0.97%
Market Closed
Market Cap:
€2.3B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
S
|
Supernus Pharmaceuticals Inc
F:S49
|
US |
|
Porr AG
F:ABS2
|
AT |
|
P
|
PennyMac Financial Services Inc
F:1AC
|
US |
|
P
|
Prudential Financial Inc
F:PLL
|
US |
|
S
|
Sturm Ruger & Company Inc
F:ST2
|
US |
|
C
|
Cleveland-Cliffs Inc
XMUN:CVA
|
US |
|
A
|
Asahi Intecc Co Ltd
F:6XT
|
JP |
|
A
|
Anika Therapeutics Inc
F:AKP
|
US |
Multiples-Based Value
The Multiples-Based Value for 
Supernus Pharmaceuticals Inc (S49) under the Base Case is hidden
EUR.
Compared with the current market price of 41.8 EUR, the stock appears hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
S49 Multiples-Based Value
LOCKED
